"We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We believe it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel."

During the past decade, Sanguine Biosciences, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanguine Biosciences, Inc." #1 collaborator was "Denali Therapeutics Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sanguine Biosciences, Inc." are "Mucopolysaccharidosis III-A" (1 trials) and "Sickle Cell Disease" (1 trials). Many other conditions were trialed in "Sanguine Biosciences, Inc." in a lesser frequency.

Most popular intervention types in "Sanguine Biosciences, Inc." are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Electronic Diary" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanguine Biosciences, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sanguine Biosciences, Inc.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sanguine Biosciences, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanguine Biosciences, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".